InvestorsHub Logo
Post# of 253565
Next 10
Followers 13
Posts 411
Boards Moderated 0
Alias Born 08/12/2022

Re: None

Tuesday, 08/16/2022 7:34:14 AM

Tuesday, August 16, 2022 7:34:14 AM

Post# of 253565
081 - Oncternal Therapeutics Drives Complete Responders with First in Class ROR1 Antagonist



$ONCT
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.